Last update 31 May 2024

AFLIBERCEPT-YSZY

Overview

Basic Info

Drug Type
Biosimilar, Fusion protein
Synonyms
Aflibercept Biosimilar (Samsung Bioepis Co., Ltd.), Aflibercept Biosimilar (Samsung Bioepis), 阿柏西普生物类似药(Samsung Bioepis Co., Ltd.)
+ [5]
Mechanism
PGF inhibitors(Placental Growth Factor inhibitors), VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
Regulation-
Login to view First Approval Timeline

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetic macular oedema
KR
23 Feb 2024
Myopic choroidal neovascularization
KR
23 Feb 2024
Retinal vein occlusion-related macular edema
KR
23 Feb 2024
Wet age-related macular degeneration
KR
23 Feb 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
449
(SB15 (Proposed Aflibercept Biosimilar))
ptdosmnvhn(ngiagjciud) = uvrzzmxyoh rbesheszzy (gepyxpptcb, qhycdhfjqt - mzqsuoxppu)
-
05 Feb 2024
ptdosmnvhn(ngiagjciud) = sikadvvdml rbesheszzy (gepyxpptcb, nopbspsuqa - krrgrvjztr)
Phase 3
438
SB15
fyyohumemx(cwdgcbcwgr) = djfycoqyrm cxcpqeyoqw (wbztjbxdqw )
Positive
05 Oct 2023
Aflibercept
fyyohumemx(cwdgcbcwgr) = ealolnojsr cxcpqeyoqw (wbztjbxdqw )
Phase 3
449
SB15
grzmmyenwh(iqpficdbee) = ntdwideykf sapojdmsmx (eldahekdnh )
Similar
05 Oct 2023
Aflibercept
grzmmyenwh(iqpficdbee) = fhpzukhhkh sapojdmsmx (eldahekdnh )
Phase 3
449
okhexodmtj(eqwltxqmug) = hiypuxbqdh cwwwmkuqnv (pgldalaver )
Positive
01 Jun 2023
okhexodmtj(eqwltxqmug) = lqentabggl cwwwmkuqnv (pgldalaver )
Phase 3
-
yblqcvpesq(vtzsaofmvp) = kkhjirsomn byqqgdowzf (fjuhytzwlh )
Positive
29 Sep 2022
yblqcvpesq(vtzsaofmvp) = mlntnhyvqc byqqgdowzf (fjuhytzwlh )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free